Table 1. Summary of patient’s clinical course.
Days after initial diagnosis | Clinical events |
---|---|
0 | Admission |
1 | Ribavirin, lopinavir/ritonavir treatment |
3 | Fever disappearance |
Negative conversion of RT-PCR for MERS-CoV | |
5 | Ribavirin, lopinavir/ritonavir stop due to adverse drug reaction |
14 | Discharge with no symptom Normal chest radiographs |
21 | Re-admission due to fever |
Newly developed consolidative opacity on chest radiographs | |
Empirical antibiotic treatment | |
23 | Suspected organizing pneumonia on chest CT |
24 | Intravenous methylprednisolone 32 mg |
25 | Fever disappearance |
Improvement of chest radiographs | |
30 | Discharge (oral methylprednisolone 28 mg) |
30–82 | Gradual tapering of methylprednisolone in outpatient clinic |
110 | Complete resolution on follow-up chest CT |
CT, computed tomography; MERS-CoV, Middle East respiratory syndrome coronavirus; RT-PCR, reverse transcription-polymerase chain reaction.